ascendis pharma glp-1 receptor agonist medications Emerging Trends in the Development of GLP-1 Receptor Agonists Ozempic maker Novo Nordisk is
Description
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
Learn about the Zepbound blindness lawsuit, including NAION and other eye side effects, and read about a study linking GLP-1 RAs to severe vision problems.
Obesity management: Used widely for weight loss, even in non-diabetic individuals
Most Americans about 92% have health insurance, either at work, through Medicare or Medicaid, or an individual Affordable Care Act (ACA) plan
